Clinical Trial Update: Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating direct left ventricular delivery of a genetic medicine aimed at organ regeneration to treat heart failure with reduced ejectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Genetic medicine for heart regeneration (experimental)

Snippet

Sponsor: YAP Therapeutics, Inc. | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 1 | Status: RECRUITING